Federal Agency · Food and Drug Administration
Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
Last updated: November 6, 2026
Posted August 14, 2024
- Who can apply
- Government agencies and municipalities, for-profit businesses, eligible organizations, and nonprofit organizations
- Amount
- $1M
- Deadline
- Rolling
- Where
- Nationwide
- Status
- Rolling — no fixed deadline
Food and Drug Administration is a federal agency that offers the Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed grant program to support research innovation. This funding opportunity is available nationally and is administered by Food and Drug Administration through Grants.gov. Organizations seeking funding for research innovation should review the details below and confirm their eligibility before preparing an application.
Eligibility
Eligible applicants include government agencies and municipalities, for-profit businesses, eligible organizations, and nonprofit organizations. Organizations that meet the eligibility criteria are encouraged to apply and to review the full program guidelines before submission. Because eligibility rules and funding priorities can change between cycles, applicants should always confirm the current requirements with Food and Drug Administration or on Grants.gov before investing time in an application.
Funding and Timeline
Funding available: $1M. This is a rolling or open-cycle opportunity with no fixed application deadline. Applicants should allow sufficient time to gather required documentation, including organizational information, project descriptions, budgets, and supporting materials as specified in the program guidelines. Submitting a complete application well ahead of the deadline reduces the risk of disqualification on technical or administrative grounds.
Program Focus
This grant supports research innovation. This grant is associated with NAICS industry classifications: 541714, 325412. Organizations operating in these sectors are encouraged to review eligibility. Funded projects are expected to demonstrate measurable outcomes aligned with the program's stated objectives. Grant recipients may be required to submit progress reports and final evaluations as a condition of the award, and to retain records for audit and compliance purposes.
How to Apply
Eligible organizations can apply through Grants.gov. Create a free organization profile on GrantRegister to see whether this grant matches your organization's NAICS code, entity type, location, and focus area, and to receive a weekly digest of every open grant you qualify for. GrantRegister maintains a complete, authoritative registry of US federal, state, and foundation grant opportunities — matched automatically to your organization profile and delivered every Monday.
Focus area
- Funded by FDA
NAICS: 541714, 325412
Award details
Award range: $1M.
Categories
Grants.gov ↗·Last verified November 6, 2026
Similar grants
- CLEAN AND SAFE WATEREnvironmental Protection Agency · closes November 8, 2026
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)National Institutes of Health · closes November 13, 2026
- Applied MathematicsU.S. National Science Foundation · closes November 16, 2026
- Plasma PhysicsU.S. National Science Foundation · closes November 16, 2026
- Small Business Innovation Research and Small Business Technology Transfer Programs Phase IINational Institute of Food and Agriculture · closes November 17, 2026
- National Science Foundation Translation to Practice (NSF TTP)U.S. National Science Foundation · closes November 17, 2026
- FY27 Small Business Development Center State of Kansas Network RebidSmall Business Administration · closes November 19, 2026
- Unlocking New Levels of Output and Capacity for Key Subsurface Resources (UNLOCK)Advanced Research Projects Agency Energy · closes November 20, 2026
